These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18508434)

  • 1. Chemokines in lupus nephritis.
    Kulkarni O; Anders HJ
    Front Biosci; 2008 May; 13():3312-20. PubMed ID: 18508434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
    Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
    Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of chemokine-mediated tissue injury in lupus nephritis.
    Vielhauer V; Anders HJ
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):313-21. PubMed ID: 17214577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis.
    Tucci M; Calvani N; Richards HB; Quatraro C; Silvestris F
    Ann N Y Acad Sci; 2005 Jun; 1051():421-32. PubMed ID: 16126984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
    Xia W; Eltrich N; Vielhauer V
    Front Immunol; 2024; 15():1377913. PubMed ID: 38799420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CCL2/MCP1: a novel target in systemic lupus erythematosus and lupus nephritis].
    Kulkarni O; Anders HJ
    Z Rheumatol; 2008 May; 67(3):220-4. PubMed ID: 18398619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine network in systemic lupus erythematous nephritis.
    Rovin BH
    Front Biosci; 2008 Jan; 13():904-22. PubMed ID: 17981599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines and Chemokine Receptors in the Development of Lupus Nephritis.
    Liao X; Pirapakaran T; Luo XM
    Mediators Inflamm; 2016; 2016():6012715. PubMed ID: 27403037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fungal lactone oxacyclododecindione is a potential new therapeutic substance in the treatment of lupus-associated kidney disease.
    Henke J; Erkel G; Brochhausen C; Kleinert H; Schwarting A; Menke J; Pautz A
    Kidney Int; 2014 Oct; 86(4):780-9. PubMed ID: 24717299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.
    Liao TD; Nakagawa P; Janic B; D'Ambrosio M; Worou ME; Peterson EL; Rhaleb NE; Yang XP; Carretero OA
    Am J Physiol Renal Physiol; 2015 May; 308(10):F1146-54. PubMed ID: 25740596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR4
    Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
    Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of monocyte chemoattractant protein 1 (MCP-1) gene polymorphism with lupus nephritis in Egyptian patients.
    Mohammad LA; Atef DM; Abul-Saoud AM
    Hum Immunol; 2015 Oct; 76(10):724-8. PubMed ID: 26429331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.
    Kanapathippillai P; Hedberg A; Fenton CG; Fenton KA
    Cytokine; 2013 May; 62(2):244-52. PubMed ID: 23561928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine blockade for lupus model mice.
    Hasegawa H
    Front Biosci; 2008 Jan; 13():2900-8. PubMed ID: 17981762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-specific STAT3 deficiency abrogates lupus nephritis.
    Yoshida N; He F; Kyttaris VC
    Lupus; 2019 Oct; 28(12):1468-1472. PubMed ID: 31551033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M; El-Gammasy T; Shaheen K; Shokr E
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal-infiltrating CD11c
    Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephritis: from pathogenesis to targets for biologic treatment.
    Liu Y; Anders HJ
    Nephron Clin Pract; 2014; 128(3-4):224-31. PubMed ID: 25401461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.